In 2024, MB Act for bio had revenue of 24.7 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 24,7k € +2.8% | 24k € | 0 € -100.0% |
Profit | - | - -100.0% | 703 € |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B70/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
MB Act for bio is located at Kaunas, J. Basanavičiaus al. 35-18, LT-50271, LT-LT-50271.
The shareholders of MB Act for bio include 1 Lithuanian legal entities. View ownership details →
Yes, MB Act for bio is registered as an active VAT payer with VAT number LT100017835110.
MB Act for bio was founded on May 28, 2021. The company has been operating for 5 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 5 years | 2 - 6 | 70% | |
Net revenue | 24 688,00 € | 5 - 9 | 40% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Lithuanian register of legal entities.